Page last updated: 2024-12-11

glucoerucin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

glucoerucin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

glucoerucin : A thia-alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose having a 5-(methylsulfanyl)-N-(sulfooxy)pentanimidoyl group attached to the anomeric sulfur. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6537200
CHEBI ID79325
SCHEMBL ID887089
MeSH IDM0305894

Synonyms (8)

Synonym
glucoerucin
21973-56-8
4-methylthiobutyl glucosinolate
SCHEMBL887089
1-s-[(1z)-5-(methylsulfanyl)-n-(sulfooxy)pentanimidoyl]-1-thio-beta-d-glucopyranose
CHEBI:79325
1-thio-b-d-glucopyranose 1-[5-(methylthio)-n-(sulfooxy)pentanimidate], 9ci
(e)-5-(methylthio)-1-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-ylthio)pentylideneaminooxysulfonic acid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" is safe and effectively enhances NQO1 in all tissues evaluated."( Evaluation of the safety and bioactivity of purified and semi-purified glucoraphanin.
Jeffery, EH; Keck, AS; Lai, RH; Wallig, MA; West, LG, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
thia-alkylglucosinolic acidA glucosinolic acid that is an alkylglucosinolic acid in which one on the carbons in the alkyl side-chain has been replaced by a sulfur or an oxidised sulfur.
organic sulfideCompounds having the structure RSR (R =/= H). Such compounds were once called thioethers.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
glucosinolate biosynthesis from dihomomethionine627

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's3 (11.11)29.6817
2010's18 (66.67)24.3611
2020's5 (18.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]